Analyses / JPM
Mega-cap bank at fair value; strong earnings growth supports modest upside near-term.
A free account reveals JPM's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
P/E 15.1x vs historical 15–17x range, forward P/E 15.6x — fair to slight discount. 17% EPS growth, strong net margin 29.3%, 1.8% yield + capital returns. Q2 earnings season catalysts. Beta ~1.0 = market-correlated. Banking-sector tailwind if rates stable.
▼ Bear Case
P/B 2.42x elevated for a bank; reversion risk if interest-rate outlook darkens. Price-to-FCF 68.8x stretched; reliance on non-deposit funding if credit cycle turns. Insider selling (111 sells vs 87 buys) suggests caution near highs. Macro slowdown or recession could crush net interest margin.
Valuation
fair — score 70/100
P/E 15.1x in-line with historical mean; forward 15.6x slightly discounted. P/B 2.42x elevated but justified by 29% net margins. P/S 3.47x reasonable for a scaled wealth-management + lending platform. EPS growth 17% supports modest premium.
Technical Levels
Support · $325.00 (10-day MA / near entry zone) · $310.00 (Stop-loss level; 50-day MA proxy) · $279.10 (52-week low)
Resistance · $343.45 (52-week high) · $360.00 (Psychological / round-number target) · $375.00 (Longer-term bull target)
Financial Health
Score 78/100. Large-cap bank with fortress-like profitability metrics. No debt-to-equity or liquidity ratios from Finnhub, but 1.79% dividend yield + proven buyback history + consistent margin strength suggest stable balance sheet. Insider selling a minor watch item; typical for executives near highs.
Catalysts
| Q2 2024 Earnings (likely mid-July) | ~2 weeks | High — NII trends, loan-loss provisions, trading revenues, and forward guidance will drive 3–5% price move. |
| Fed Rate Decision (June / July FOMC) | Within 4 weeks | High — JPM NIM sensitive to rates. Hold signals support, cut signals headwind. |
| Umicore Stake News | Ongoing | Low–medium — strategic battery-materials play; upside optionality, not core earnings driver. |
Risk Flags
See JPM's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock JPM free →Recent News
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full JPM analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
JPM FAQ
Is JPM a buy right now?
JPMorgan Chase & Co's current read is a value-with-growth setup with 68 confidence over a 3–6 months horizon. Valuation: fair. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is JPM overvalued?
fair (valuation score 70/100). P/E 15.1x in-line with historical mean; forward 15.6x slightly discounted. P/B 2.42x elevated but justified by 29% net margins. P/S 3.47x reasonable for a scaled wealth-management + lending platform. EPS growth 17% supports modest premium.
What are the risks of buying JPM?
P/B 2.42x elevated for a bank; reversion risk if interest-rate outlook darkens. Price-to-FCF 68.8x stretched; reliance on non-deposit funding if credit cycle turns. Insider selling (111 sells vs 87 buys) suggests caution near highs. Macro slowdown or recession could crush net interest margin.